Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €76.19 EUR
Change Today +0.161 / 0.21%
Volume 91.0
DC4 On Other Exchanges
DC4 is not on other exchanges.
As of 3:54 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

dexcom inc (DC4) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/23/15 - €79.04
52 Week Low
08/1/14 - €26.53
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for DEXCOM INC (DC4)

dexcom inc (DC4) Related Businessweek News

No Related Businessweek News Found

dexcom inc (DC4) Details

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. Its ambulatory product line includes DexCom G4 system, a continuous glucose monitoring system; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom SHARE, a remote monitoring system, which provides secondary notification and does not replace real time continuous glucose monitoring or standard home blood glucose monitoring. Its in-hospital product line comprises GlucoClear, a blood-based in-vivo automated glucose monitoring system for use by healthcare providers in the hospital. The company also offers SweetSpot, a software platform that enables patients to aggregate and analyze data from diabetes devices and to share it with their healthcare providers. DexCom, Inc. markets its products directly to endocrinologists, physicians, and diabetes educators primarily in the United States. The company was founded in 1999 and is headquartered in San Diego, California.

838 Employees
Last Reported Date: 02/25/15
Founded in 1999

dexcom inc (DC4) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $325.0K
Executive Chairman
Total Annual Compensation: $420.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $248.9K
Chief Technical Officer and Executive Vice Pr...
Total Annual Compensation: $296.4K
Executive Vice President of Strategy & Corpor...
Total Annual Compensation: $296.4K
Compensation as of Fiscal Year 2014.

dexcom inc (DC4) Key Developments

DexCom, Inc.(NasdaqGS:DXCM) added to Russell 1000 Index

DexCom, Inc. has been added to Russell 1000 Index.

DexCom, Inc.(NasdaqGS:DXCM) dropped from Russell 2000 Index

DexCom, Inc. will be removed from Russell 2000 Index

DexCom, Inc. Announces Availability of Follow App for Android Devices

Dexcom, Inc. has announced the availability of the Follow app for Android devices. The app is a component of the Dexcom G4 PLATINUM Continuous Glucose Monitor System with Share, the industry's first mobile-connected CGM system. Already available to iOS-enabled devices, the Follow app allows family members, friends and caregivers 'Followers' to remotely view a loved one's glucose data and trends on their smart device, giving them peace of mind and reassurance when they are apart. CGM users 'Sharers' can invite up to five Followers to view their glucose information via the Follow app. The Followers can view the Sharer's glucose data and trends, as well as choose to receive alerts and notifications when the Sharer's glucose levels are outside specified ranges.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DC4:GR €76.19 EUR +0.161

DC4 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $50.69 USD -0.08
Insulet Corp $33.89 USD +0.34
Merge Healthcare Inc $5.49 USD -0.01
Smiths Group PLC 1,129 GBp -6.00
Tandem Diabetes Care Inc $12.55 USD +1.01
View Industry Companies

Industry Analysis


Industry Average

Valuation DC4 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 22.9x
Price/Book 44.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 23.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DEXCOM INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at